Abstract. Interferon (IFN)-γ plays a critical role in murine uterine spiral artery remodeling for successful pregnancy. The effect of IFN-γ on human uterine microvasculature, however, remains poorly understood. The aim of this study was to identify the genes regulated by IFN-γ in human uterine microvascular endothelial cells. The effect of IFN-γ on the gene expression profile in human uterine microvascular endothelial cells was evaluated by cDNA microarray analysis and quantitative real-time reverse transcriptase-polymerase chain reaction for the selected genes of interest. In vivo expression of the protein encoded by some of these genes in human uterine microvascular endothelial cells was evaluated by Western blotting and immunohistochemistry. Treatment with 10 ng/ml IFN-γ for 4 h induced a significant ≥2-fold change in 29 genes in pooled human uterine microvascular endothelial cells; a total of 20 genes were up-regulated, whereas nine genes were down-regulated. The genes significantly up-regulated included chemokines (CXCL9, CXCL10, CCL8, IL15RA, and CCL5), enzymes (GBP5, TAP1, CYP27B1, SOD2, MX1, CASP1, and PTGES), and transcription factors (TFAP2C, IRF1, NFE2L3). The genes significantly down-regulated following IFN-γ treatment included cytokines/cytokine receptors (CSF2, IL1R2, and SPP1), and insulin-like growth factor binding proteins (WISP2 and IGFBP3) . The results of the cDNA microarray analysis were confirmed by quantitative real-time reverse transcriptase-polymerase chain reaction for the selected 17 genes of interest. The immunoreactivity for the proteins encoded by IL15RA, IFI30, and MX1 was detected in human uterine microvascular endothelial cells in vivo, whereas the immunoreactivity for CCNA1 and NQO1 was not detectable. These results suggest that IFN-γ regulates the gene expression involved in natural killer cell recruitment, embryo and trophoblast migration, endometrial decidualization, angiogenesis, angiostasis, and anti-viral infection in human uterine microvascular endothelial cells.
Introduction
Efficient uterine blood supply to the implantation site is a prerequisite for successful embryo and placental development. After ovulation, the peripheral branches of the uterine arteries develop through the inner myometrium and whole endometrium in a helicoid form (defined as uterine spiral arteries) and nourish the uterine wall layers. If the embryo is implanted successfully into the endometrium, uterine spiral arteries further develop in the decidualized endometrium towards the fetal site to supply the maternal blood flow to intervillous spaces of the placenta. During human placentation, a cluster of cytotrophoblasts differentiate into the invasive phenotype in the cell column of the anchoring villi, migrate into the uterine spiral arteries, and replace the endothelial cells of the uterine spiral arteries. This remodeling of the uterine spiral arteries by invading trophoblasts leads to the loss of arterial contractility, which enables constant maternal blood flow into the intervillous spaces to support placental function (1) .
Interferon (IFN)-γ, a cytokine produced by various cell types, shows a wide range of biological activities in mammalian species. Studies have revealed the potential roles of IFN-γ in successful reproduction. In the murine uterus, IFN-γ originates in leukocytes of natural killer cell lineage infiltrating decidua basalis, mesometrial triangle, and mesometrial lymphoid aggregates of pregnancy (transient lymphoid structures develop in the myometrium at the implantation sites surrounding the uterine arterial branches) (2) . Pregnant mice lacking the IFN-γ gene display impaired uterine spiral artery remodeling, endometrial decidualization, smaller litter size, and increased fetal losses, which resemble the histopathological and clinical findings seen in preeclampsia (3) . These findings suggest that IFN-γ modifies the gene expression in uterine microvessels, which is important for instability and remodeling of uterine microvasculature during pregnancy (2) .
In humans, IFN-γ is expressed in uterine intraepithelial lymphocytes and endometrial stromal polymorphonuclear neutrophils under nonpregnant conditions (4) . After embryo implantation, IFN-γ is also produced by CD16(-) natural killer cells infiltrating the decidualized endometrial stroma (5) . IFN-γ induces in vitro proliferation and differentiation of human uterine epithelial cells and endometrial stromal fibroblasts (6) (7) (8) , and regulates the invasion of the extravillous trophoblasts into decidualized endometrium (9, 10) . In contrast, the effect of IFN-γ on human uterine microvasculature remains poorly understood.
This study was conducted to obtain a comprehensive view on the effect of IFN-γ on the gene expression profile in human uterine microvascular endothelial cells. Using cDNA microarray analysis, we investigated the change in gene expression induced by IFN-γ in these cells. We confirmed the results by quantitative real-time reverse transcriptasepolymerase chain reaction for the selected genes of interest. In addition, we investigated in vivo protein expression encoded by some of these genes in the human uterine microvascular endothelial cells.
Materials and methods

Antibodies and reagents.
Mouse anti-human IFN-γ receptor α chain monoclonal antibody (GIR-94, sc12775), goat antihuman IFN-γ receptor ß chain polyclonal antibody (C-20, sc970), goat anti-human myxovirus resistance 1 (MX1) polyclonal antibody (D-14, sc34128), goat anti-interferoninducible protein 30 (IFI30) polyclonal antibody (T-18, sc21827), rabbit anti-cyclin A1 (CCNA1) polyclonal antibody (H432, sc751), mouse anti-NAD(P)H quinone oxidoreductase 1 (NQO1) monoclonal antibody (A180, sc32793), and the corresponding control isotype-matched immunoglobulin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Blocking peptides for each antibody were also purchased from Santa Cruz Biotechnology. Goat antihuman interleukin-15 receptor α chain (IL15RA) polyclonal antibody (AF247) and recombinant human IL-15 receptor α chain/Fc chimera (147-IR, extracellular domain of IL-15 receptor α chain) were purchased from R&D Systems (Minneapolis, MN).
Samples. Human myometrial and endometrial samples were obtained from 20 fertile women aged 32-45 years, who had undergone hysterectomy for cervical carcinoma in situ (n=18) and cervical dysplasia (n=2). Informed consent was obtained from each patient before the operation. They had regular menstrual cycles ranging from 28 to 35 days and were not receiving any hormonal treatment. None of these samples showed any pathological findings such as polyps, leiomyomas, adenomyosis or endometritis. Following the standard criteria for endometrial dating (11), 5, 4, 6, and 5 samples were classified into the proliferative phase, early secretory phase, mid-secretory phase, and late secretory phase, respectively. The samples were collected immediately after hysterectomy and washed in phosphate-buffered saline (PBS). A portion of the samples was fixed overnight in a 4% paraformaldehyde [in phosphate buffer (pH 7.
3)] and embedded in paraffin. The remainder was homogenized and solubilized in lysis buffer (2 μM aprotinin, 50 μM leupeptin, 125 μM bestatin, and 25 μM pepstatin A; Nacalai Tesque, Kyoto, Japan). The protein concentration in the soluble protein fraction was measured with a DC protein assay kit (Bio-Rad Laboratories, Hercules, CA). The soluble protein fraction was preserved at -80˚C until assay. This study was approved by the Kyoto Prefectural University of Medicine Institutional Review Board.
Cell culture. Pooled human uterine microvascular endothelial cells were purchased from Cambrex (Walkersville, MD). By immunostaining, >98% of cells were CD34(+) and smooth muscle actin (-) throughout the cell culture and passage (Fig. 1A) , which are consistent with the phenotypes of the endothelial cells (12) . The soluble protein fraction was extracted from the cells using Trizol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. The expression of IFN-γ receptor subunits was examined by immunoreactivity with 2 μg/ml anti-IFN-γ receptor α or ß chain antibody. The cells were maintained in 6-well plates with 4 ml phenol-red free medium 199 (Invitrogen) supplemented with 30 mM HEPES buffer, 10% charcoalstripped fetal calf serum, 100 IU/ml penicillin, 100 μg/ml streptomycin, and 2.5 μg/ml amphotericin B. The cells from passage 2-4 were treated with or without 10 ng/ml recombinant human IFN-γ for 4 or 24 h and pooled from three different wells. The experiments were performed in triplicate.
Microarray analysis. Total RNA was extracted using Trizol reagent, purified using DNase (Invitrogen) and the RNeasy mini kit (Qiagen, Valencia, CA), and dissolved in RNase-free water. The purity and amount were measured by OD260/ OD280 absorbance ratio and electrophoresis on an agarose gel. First-and second-strand cDNAs were synthesized from 5 μg total RNA using the oligodeoxythymidine 24 primer containing T7 promoter sequence (Qiagen). cRNA was synthesized from second-strand cDNA with aminoallyl-UTP (Applied Biosystems, Ambion, Foster City, CA) using Superscript RNA Amplification System (Invitrogen) and labeled with Cy-5 and Cy-3 (Qiagen). cRNA was hybridized to oligo DNA chip (Hitachi Human Chip ver. 1, Hitachi Life Science, Tokyo, Japan) overnight at 45˚C. The chips were scanned using ScanArray 5000 (GSI Lumonics, Billerica, MA). The image data were converted to the intensity value data and analyzed by subtracting the backgrounds using the QuantArray software (GSI Lumonics). The intensity values for DNA duplicate probes were averaged. Following normal globalization method, the data were subjected to serial pairwise comparisons. The relative intensity values (Cy-5/Cy-3) for the genes were statistically analyzed using DNASIS array ver. 2.6 (Hitachi Life Science). The one-way analysis of variance test was used to estimate the p value for every gene without the post-hoc test. Benjamini-Hochberg multiple testing correction was used for the false discovery rate (13) .
Quantitative real-time reverse transcriptase-polymerase chain reaction. cDNA was synthesized from 2 μg total RNA with 1 μg of oligodeoxythymidine primers by 250 U Superscript II reverse transcriptase (Invitrogen) in a final volume of 25 μl. This solution was subjected to polymerase chain reaction with a QuantiTect SYBR-Green polymerase chain reaction kit (Applied Biosystems) and the specific primers (0.5 μM) for the genes of interest (Table I) following the manufacturer's protocol. Each cycle consisted of denaturation (30 sec at 94˚C), annealing (30 sec at 60˚C), and elongation (30 sec at 72˚C). As an internal control, human RPL19, a less variable gene in expression levels in the human endometrium (14, and in this study) compared with other known housekeeping genes was simultaneously amplified under the same condition. We confirmed the specificity of the reaction by amplification of the RNA solution without reverse transcriptase and electrophoresis of the polymerase chain reaction products on an agarose gel. Fluorescent data were obtained during the annealing and elongation of each cycle using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems). The sequence of the polymerase chain reaction products was confirmed with a Sequence Scanner ver. 1.0 (Applied Biosystems).
Western blot analysis. The myometrial and endometrial soluble protein fraction was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrotransferred to a polyvinylidene difluoride membrane (BioRad Laboratories). The membrane was incubated with 5% nonfat milk in Tris-buffered saline-T (containing 0.1 M NaCl, 0.01 M Tris, 0.1% Tween-20) to reduce nonspecific antibody binding. The membrane was then incubated with one of the following primary antibodies; anti-IL15RA (2 μg/ml), anti-MX1 (1 μg/ml), anti-IFI30 (2 μg/ml), anti-CCNA1 (4 μg/ml) or anti-NQO1 (10 μg/ml). The control immunoglobulin was used to exclude background staining. After being washed, the membrane was incubated with a secondary antibody conjugated with horseradish peroxidase (1:10,000 dilution; Santa Cruz Biotechnology). Immunoreactivity was detected with enhanced chemiluminescence using ECL Plus detection kit (Amersham-Pharmacia, Uppsala, Sweden).
Immunohistochemistry. Fixed samples were embedded in paraffin and cut into 4-μm sections. After being deparaffinized in xylene and rehydrated in a graded series of ethanol, sections were immersed in 3% hydrogen peroxide for 5 min to block endogenous peroxidase and then incubated with PBS containing 10% fetal calf serum for 10 min at room temperature to suppress nonspecific antibody binding. In a moist chamber, sections were incubated with one of the following antibodies overnight at 4˚C; anti-IL15RA (5 μg/ ml), anti-MX1 (10 μg/ml), anti-IFI30 (10 μg/ml), or anti-CCNA1 (20 μg/ml). To achieve optimal immunostaining, in some sections, microwave treatment of deparaffinized sections with 0.1 M citrate buffer (pH 6.0; Dako, Kyoto, Japan) was performed prior to the incubation with primary antibodies. The control isotype-matched immunoglobulin was used to exclude background staining. After being washed in PBS, the section was incubated with a LASB kit (Dako). Sections were washed and developed with diaminobenzidine (Dako).
Results
Genes significantly up-or down-regulated by IFN-γ in human
uterine microvascular endothelial cells. The immunoreactivity for IFN-γ receptor α chain was detected at 90 kDa as a single band in the human uterine microvascular endothelial cells (Fig. 1B) . The immunoreactivity for IFN-γ receptor ß chain was detected at 38 kDa as a single band. Using cDNA microarray analysis, we examined the effect of IFN-γ on 1,873 genes in the human uterine microvascular endothelial cells. Treatment of the cells with 10 ng/ml IFN-γ for 4 h induced a significant ≥2-fold change in 36 genes in experiment 1, 41 genes in experiment 2, and 37 genes in experiment 3. The number of genes that displayed a significant ≥2-fold change (p<0.05) in all three independent experiments was 29. Of these 29 genes, a total of 20 genes were up-regulated, whereas nine genes were down-regulated (Table II) . The genes significantly up-regulated included chemokines (CXCL9, CXCL10, CCL8, IL15RA, and CCL5), enzymes (GBP5, TAP1, CYP27B1, SOD2, MX1, CASP1, and PTGES), and transcription factors (TFAP2C, IRF1, NFE2L3) . The genes significantly down-regulated following IFN-γ treatment included cytokines/cytokine receptors (CSF2, IL1R2, and SPP1), and insulin-like growth factor binding proteins (WISP2 and IGFBP3) . Following an additional 20-h treatment, 4 genes (CSH2, ICAM1, TAP1, and IL15RA) were further up-regulated, whereas 2 genes (WISP2 and IGFBP3) were further down-regulated.
To confirm the results of the microarray analysis, we In vivo protein expression encoded by genes regulated by IFN-γ in human uterine microvascular endothelial cells. To clarify whether the genes up-or down-regulated by IFN-γ were expressed in vivo in human uterine microvascular endothelial cells at a protein level, we examined the expression of five proteins (IL15RA, IFI30, MX1, CCNA1, and NQO1), whose encoding protein expression in these cells remains undetermined. By Western blotting, the immunoreactivity for Table I . Primer pairs used for quantitative real-time reverse transcriptase-polymerase chain reaction.
Forward primer Reverse primer Prospected product size (base pairs)
Chemokine (C-X-C motif) ligand 10 (CXCL10) aggaacctccagtctcagca caaaattggcttgcaggaat 192
Interferon Table II . Genes up-or down-regulated in human uterine microvascular endothelial cells following 10 ng/ml recombinant human IFN-γ treatment for 4 and 24 h.
-----------------------------------------------------------------------------------------------------
a -----------------------------------------------------------------------------------------------------
Gene name (gene symbol) GenBank Gene ontology Fold change accession no.
- 
-------------4 h 24 h -----------------------------------------------------------------------------------------------------
(connexin 37) (GJA4) ----------------------------------------------------------------------------------------------------------------------------------------------------------------Down-regulated genes
Colony stimulating factor 2 M11734 Cytokine, granulocyte macrophage 0.15 0.31 (granulocyte-macrophage) (CSF2) colony-stimulating factor receptor binding IL15RA (55 kDa), IFI30 (30 kDa), and MX1 (75 kDa) was detected in the soluble protein fraction extracted from human myometrial and endometrial samples as well as the positive control placental tissue. The immunoreactivity for CCNA1 (54 kDa) was detected in the endometrium in the proliferative phase at a very low level. The immunoreactivity for NQO1 was not detectable in any samples examined (Fig. 2) .
To identify the localization of these proteins in the human myometrium and endometrium, we performed immunohistochemistry using paraffin-embedded sections. The immunoreactivity for IL15RA, MX1, and IFI30 was detected in the cytoplasm of the stromal and endothelial cells in the myometrium and in the cytoplasm of the epithelial, stromal, and endothelial cells in the endometrium (Fig. 3A and C-G) . The immunoreactivity was blocked by immunoabsorption test (Fig. 3B) . The immunostaining intensity for IL15RA was greater in the endothelial and epithelial cells than in the stromal cells. The immunostaining intensity for MX1 and IFI30 was greater in the functional layer of the endometrium than in the basal layer of the endometrium and the myometrium. In the proliferative phase, the immunoreactivity for CCNA1 was detected in <10% of the endometrial epithelial cells and <1% of the endometrial stromal cells, but not detected in the endometrial microvascular endothelial cells (Fig. 3H) . Table II . Continued.
GenBank Gene ontology Fold change accession no.
The genes showing a significant ≥2-fold change in all three independent experiments are listed. The fold change indicates the mean value of three independent experiments.
Discussion
Using cDNA microarray analysis and quantitative real-time reverse transcriptase-polymerase chain reaction, we identified the genes up-or down-regulated by IFN-γ in human uterine microvascular endothelial cells. Treatment of the cells with 10 ng/ml IFN-γ for 4 h induced a significant ≥2-fold change in more than 35 genes in each experiment. We narrowed the number of genes down to 29 which showed a significant ≥2-fold change in all three independent experiments.
The gene cluster that was most highly up-regulated was the chemokines including CXCL9, CXCL10, CCL8, CCL5, and IL15RA. CXCL9, CXCL10, and CCL5 are expressed at the protein level in human endometrial microvascular endothelial cells (15, 16) , while CCL8 is not expressed in these cells in vivo (17) . In this study, we first demonstrated that IL15RA is expressed in uterine microvascular endothelial cells. CXCL9, CXCL10, CCL5, and the soluble form of protein IL15RA have strong chemotactic activities for CD16(-) natural killer cells, which acutely increase in number in secretory phase endometrium (18) (19) (20) (21) . In this context, ICAM1, an adhesion molecule which is expressed in endometrial microvascular endothelial cells and plays a critical role in leukocyte tight adhesion to endothelial cells (22) , was also significantly up-regulated by IFN-γ. IFN-γ is known to induce selective transendothelial migration of peripheral blood CD16(-) natural killer cells in vitro (23) . It is likely that IFN-γ plays a role in transendothelial migration of CD16(-) natural killer cells across endometrial microvascular endothelial cells by enhancing the expression of these genes.
Some chemokines also have a potential chemotactic activity for embryonic cells. For example, CCL5 is a chemoattractant for human invading trophoblasts and blastocysts (24, 25) , whereas CXCL10 shows a chemotactic activity for murine blastocysts (26) . Human endometrial perivascular stromal cells express smooth muscle actin and have contractile activity, which are characteristic of myofibroblasts (12, 27) . These cells show marked proliferation in response to progesterone and spread in the endometrial stroma (28) . CXCL9 and CXCL10 can stimulate the proliferation of myofibroblast-like renal perivascular cells (29) . These chemokines may be involved in the process of decidualization.
Several genes encoding enzymes (GBP5, TAP1, CYP27B1, SOD2, MX1, CASP1, and PTGES) were also significantly up-regulated by IFN-γ. CYP27B1 is the gene encoding 1,25-dihydroxyvitamin D 3 1α-hydroxylase. This enzyme catalyzes the synthesis of 1,25-dihydroxyvitamin D 3 which exerts immunosuppressive effects on CD16(-) natural killer cells in the endometrium (30, 31) . The active form of this enzyme is expressed in the endothelial cells in the decidualized endometrium (30) . The proteins encoded by CASP1 and PTGES are also expressed in uterine microvascular endothelial cells in vivo (32, 33) , while GBP5, TAP1, and SOD2 are not expressed (34) (35) (36) . The role of CASP1 and PTGES in angiogenesis is speculated. For example, interleukin-1ß, which is synthesized by caspase 1 (protein encoded by CASP1), acts as an angiogenic growth factor (37) . Similarly, prostaglandin E, which is synthesized by prostaglandin E synthase (protein encoded by PTGES), can induce vasodilation and angiogenesis (38) .
IFN-γ up-regulated the genes CXCL9 and CXCL10 for angiostasis. In addition to chemotactic activity, CXCL9 and CXCL10 display angiostatic activity through a protein kinase A-mediated inhibition of m-calpain (39) . The downregulation of several genes for angiogenesis, such as CSF2, SPP1, and IL1R2 is in agreement with these findings. Indeed, CSF2, SPP1, and IL1R2 are not expressed in uterine microvascular endothelial cells in vivo (40) (41) (42) , suggesting the involvement of IFN-γ in the functional regulation of these genes. CCNA1 is the cell cycle promoter gene important for DNA synthesis and germ cell meiosis (43) . A recent study showed the potential role of CCNA1 in the proliferation of human endometrial epithelial and stromal cells (44) . In this study, CCNA1 was not detectable in the uterine microvascular endothelial cells. Thus, IFN-γ probably contributes to the uterine microvasculature integrity by regulating the balance between angiogenesis and angiostasis.
The transcription factors, TFAP2C, IRF1, and NFE2L3 were up-regulated by IFN-γ. TFAP2C and IRF1 are not expressed in uterine microvascular endothelial cells in vivo (45) (46) (47) . NFE2L3 has been suggested to play a potential role in placental gene expression and development (48) . Interestingly, a previous study demonstrated that NFE2L3 is a negative regulator of NAD(P)H dehydrogenase NQO1 (49) . We found that IFN-γ down-regulated NQO1 expression in the uterine microvascular endothelial cells and NQO1 was not expressed in these cells in vivo. These findings suggest that IFN-γ modulates the expression status of NFE2L3 and NQO1 in uterine microvascular endothelial cells.
Also up-regulated were the genes for anti-viral infection IFI30 and MX1. IFI30 is a lysosomal protein that has a potential to induce CD8(+) T cell expansion against foreign antigens (50) , while MX1 plays an active role against influenza A virus and rhabdovirus (51) . We detected both proteins in the uterine microvascular endothelial cells.
IFN-γ down-regulated two genes for insulin growth factor binding, WISP2 and IGFBP3. WISP2 is not expressed in human uterine microvascular endothelial cells at the protein level, whereas the protein encoded by IGFBP3 is expressed in the myometrial microvascular endothelial cells in vivo, but not in endometrial microvascular endothelial cells (52) . The role of IGFBP3 in endothelial cells remains controversial; some investigators proposed the potential role of this gene in the growth of endothelial cells (53) , while others found an inhibitory effect (54) . The role of IGFBP3 in myometrial endothelial cells remains unclear.
In this study, we identified the genes regulated by IFN-γ in human uterine microvascular endothelial cells in vitro. IFN-γ induced the genes involved in natural killer cell recruitment, embryo and trophoblast migration, endometrial decidualization, angiogenesis, angiostasis, and anti-viral infection. These findings suggest that IFN-γ modulates gene expression in human uterine microvascular endothelial cells, which plays an important role in embryo implantation and placentation.
